NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE88887 Query DataSets for GSE88887
Status Public on Oct 25, 2016
Title Gene expression and pharmacodynamic-induced changes in 1760 SLE Patients from two phase III trials of B cell activating factor blockade with tabalumab
Organism Homo sapiens
Experiment type Expression profiling by array
Summary This SuperSeries is composed of the SubSeries listed below.
 
Overall design Refer to individual Series
 
Contributor(s) Hoffman RW, Dow ER, Perumal NB
Citation(s) 27723281, 31790472
Submission date Oct 18, 2016
Last update date Dec 31, 2019
Contact name Robert W Hoffman
E-mail(s) hoffman_robert_w@lilly.com
Phone 1 317 651 4209
Organization name Eli Lilly and Company
Department Lilly Bio-Medicines/Immunology
Street address Lilly Corporate Center
City Indianapolis
State/province IN
ZIP/Postal code 46285
Country USA
 
Platforms (1)
GPL17586 [HTA-2_0] Affymetrix Human Transcriptome Array 2.0 [transcript (gene) version]
Samples (3146)
GSM2350873 SUBJ.1307, Normal, baseline
GSM2350874 SUBJ.1378, Normal, baseline
GSM2350875 SUBJ.1280, Normal, baseline
This SuperSeries is composed of the following SubSeries:
GSE88884 Gene expression changes in baseline SLE patients vs. healthy controls from two phase III trials (ILLUMINATE-1 and ILLUMINATE-2) of B cell activating factor blockade with tabalumab
GSE88885 Pharmacodynamic-induced changes in SLE Patients from the ILLUMINATE-1 phase III trial of B cell activating factor blockade with tabalumab
GSE88886 Pharmacodynamic-induced changes in SLE Patients from the ILLUMINATE-2 phase III trial of B cell activating factor blockade with tabalumab
Relations
BioProject PRJNA350538

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE88887_RAW.tar 73.1 Gb (http)(custom) TAR (of CEL)

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap